Clinical Study

Insights on Embolic Protection, Repositioning, and Stroke: A Subanalysis of the RESPOND Study

Table 3

Effect of valve repositioning and cerebral embolic protection use on acute stroke.

Stroke ≤72 hr after TAVRValve repositioningNo repositioning value
N = 313N = 683

With CEPn = 31n = 611.00
 All-stroke0.0% (0)1.7% (1)
No CEPn = 282n = 6220.81
 All-stroke2.8% (8)2.6% (16)